Crinetics Pharmaceuticals (CRNX) Amortizatization of Intangibles (2019 - 2026)
Crinetics Pharmaceuticals' quarterly Amortizatization of Intangibles came in at $2.2 million in Q1 2026, down 49.27% year-on-year from $4.4 million in Q1 2025, and up 239.45% quarter-over-quarter from $654000.0 in Q4 2025.
Crinetics Pharmaceuticals has reported Amortizatization of Intangibles for 8 years, with the latest figure at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 49.27% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $858000.0 (down 75.97% YoY), and the FY2025 full-year result was $3.0 million, down 0.92% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $2.2 million, up from $654000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $4.7 million in Q2 2025, with the low at -$6.7 million in Q3 2025.
- Average Amortizatization of Intangibles over 5 years is $853705.9, with a median of $759000.0 recorded in 2024.
- Year-over-year, Amortizatization of Intangibles surged 921.08% in 2023 and tumbled 499.04% in 2024.
- Tracing CRNX's Amortizatization of Intangibles over 5 years: stood at $351000.0 in 2022, then surged by 921.08% to $3.6 million in 2023, then plunged by 78.82% to $759000.0 in 2024, then declined by 13.83% to $654000.0 in 2025, then jumped by 239.45% to $2.2 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.2 million (Q1 2026), $654000.0 (Q4 2025), and -$6.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 654,000.00 |
| Dec 31, 2025 | 654,000.00 |
| Sep 30, 2025 | -6.73 Mn |
| Sep 30, 2025 | -6.73 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.38 Mn |
| Mar 31, 2025 | 4.38 Mn |
| Dec 31, 2024 | 759,000.00 |
| Dec 31, 2024 | 759,000.00 |
| Sep 30, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 911,000.00 |
| Jun 30, 2023 | 911,000.00 |
| Mar 31, 2023 | 530,000.00 |
| Mar 31, 2023 | 530,000.00 |
| Dec 31, 2022 | 351,000.00 |
| Dec 31, 2022 | 351,000.00 |
| Sep 30, 2022 | 132,000.00 |
| Sep 30, 2022 | 132,000.00 |
| Jun 30, 2022 | -195,000.00 |
| Jun 30, 2022 | -195,000.00 |
| Mar 31, 2022 | -322,000.00 |
| Mar 31, 2022 | -322,000.00 |
| Dec 31, 2021 | -186,000.00 |
| Dec 31, 2021 | -186,000.00 |
| Sep 30, 2021 | -66,000.00 |
| Sep 30, 2021 | -66,000.00 |
| Jun 30, 2021 | -87,000.00 |
| Jun 30, 2021 | -87,000.00 |
| Mar 31, 2021 | -83,000.00 |
| Mar 31, 2021 | -83,000.00 |
| Dec 31, 2020 | -66,000.00 |
| Dec 31, 2020 | -66,000.00 |
| Jun 30, 2020 | 113,000.00 |
| Jun 30, 2020 | 113,000.00 |
| Mar 31, 2020 | 180,000.00 |
| Mar 31, 2020 | 180,000.00 |
| Dec 31, 2019 | 220,000.00 |
| Dec 31, 2019 | 220,000.00 |
| Sep 30, 2019 | 320,000.00 |
| Sep 30, 2019 | 320,000.00 |
| Jun 30, 2019 | 289,000.00 |
| Jun 30, 2019 | 289,000.00 |
| Mar 31, 2019 | 400,000.00 |
| Mar 31, 2019 | 400,000.00 |